203 related articles for article (PubMed ID: 29104991)
1. Biomimetics: reconstitution of low-density lipoprotein for targeted drug delivery and related theranostic applications.
Zhu C; Xia Y
Chem Soc Rev; 2017 Dec; 46(24):7668-7682. PubMed ID: 29104991
[TBL] [Abstract][Full Text] [Related]
2. Lipoprotein nanoplatform for targeted delivery of diagnostic and therapeutic agents.
Glickson JD; Lund-Katz S; Zhou R; Choi H; Chen IW; Li H; Corbin I; Popov AV; Cao W; Song L; Qi C; Marotta D; Nelson DS; Chen J; Chance B; Zheng G
Mol Imaging; 2008; 7(2):101-10. PubMed ID: 18706292
[TBL] [Abstract][Full Text] [Related]
3. Low-density lipoprotein nanomedicines: mechanisms of targeting, biology, and theranostic potential.
Di L; Maiseyeu A
Drug Deliv; 2021 Dec; 28(1):408-421. PubMed ID: 33594923
[TBL] [Abstract][Full Text] [Related]
4. Tumor-targeted delivery of paclitaxel using low density lipoprotein-mimetic solid lipid nanoparticles.
Kim JH; Kim Y; Bae KH; Park TG; Lee JH; Park K
Mol Pharm; 2015 Apr; 12(4):1230-41. PubMed ID: 25686010
[TBL] [Abstract][Full Text] [Related]
5. Synthetic lipoprotein as nano-material vehicle in the targeted drug delivery.
Zhang X; Huang G
Drug Deliv; 2017 Dec; 24(sup1):16-21. PubMed ID: 29069931
[TBL] [Abstract][Full Text] [Related]
6. Cancer targeted drug delivery using active low-density lipoprotein nanoparticles encapsulated pyrimidines heterocyclic anticancer agents as microtubule inhibitors.
Jaragh-Alhadad L; Behbehani H; Karnik S
Drug Deliv; 2022 Dec; 29(1):2759-2772. PubMed ID: 36029014
[TBL] [Abstract][Full Text] [Related]
7. Lipoprotein-Related and Apolipoprotein-Mediated Delivery Systems for Drug Targeting and Imaging.
Almer G; Mangge H; Zimmer A; Prassl R
Curr Med Chem; 2015; 22(31):3631-51. PubMed ID: 26180001
[TBL] [Abstract][Full Text] [Related]
8. Enhanced blood-brain barrier penetration and glioma therapy mediated by T7 peptide-modified low-density lipoprotein particles.
Liang M; Gao C; Wang Y; Gong W; Fu S; Cui L; Zhou Z; Chu X; Zhang Y; Liu Q; Zhao X; Zhao B; Yang M; Li Z; Yang C; Xie X; Yang Y; Gao C
Drug Deliv; 2018 Nov; 25(1):1652-1663. PubMed ID: 30394123
[TBL] [Abstract][Full Text] [Related]
9. Naphthalocyanine-reconstituted LDL nanoparticles for in vivo cancer imaging and treatment.
Song L; Li H; Sunar U; Chen J; Corbin I; Yodh AG; Zheng G
Int J Nanomedicine; 2007; 2(4):767-74. PubMed ID: 18203443
[TBL] [Abstract][Full Text] [Related]
10. Benefits of hypericin transport and delivery by low- and high-density lipoproteins to cancer cells: From in vitro to ex ovo.
Lenkavska L; Blascakova L; Jurasekova Z; Macajova M; Bilcik B; Cavarga I; Miskovsky P; Huntosova V
Photodiagnosis Photodyn Ther; 2019 Mar; 25():214-224. PubMed ID: 30597213
[TBL] [Abstract][Full Text] [Related]
11. High payload delivery of optical imaging and photodynamic therapy agents to tumors using phthalocyanine-reconstituted low-density lipoprotein nanoparticles.
Li H; Marotta DE; Kim S; Busch TM; Wileyto EP; Zheng G
J Biomed Opt; 2005; 10(4):41203. PubMed ID: 16178627
[TBL] [Abstract][Full Text] [Related]
12. Recombinant lipoproteins: lipoprotein-like lipid particles for drug targeting.
Rensen PC; de Vrueh RL; Kuiper J; Bijsterbosch MK; Biessen EA; van Berkel TJ
Adv Drug Deliv Rev; 2001 Apr; 47(2-3):251-76. PubMed ID: 11311995
[TBL] [Abstract][Full Text] [Related]
13. Natural low- and high-density lipoproteins as mighty bio-nanocarriers for anticancer drug delivery.
Mahmoudian M; Salatin S; Khosroushahi AY
Cancer Chemother Pharmacol; 2018 Sep; 82(3):371-382. PubMed ID: 29915981
[TBL] [Abstract][Full Text] [Related]
14. Artificial High Density Lipoprotein Nanoparticles in Cardiovascular Research.
Kornmueller K; Vidakovic I; Prassl R
Molecules; 2019 Aug; 24(15):. PubMed ID: 31382521
[TBL] [Abstract][Full Text] [Related]
15. Reconstitution of Low-Density Lipoproteins with Fatty Acids for the Targeted Delivery of Drugs into Cancer Cells.
Zhu C; Pradhan P; Huo D; Xue J; Shen S; Roy K; Xia Y
Angew Chem Int Ed Engl; 2017 Aug; 56(35):10399-10402. PubMed ID: 28646542
[TBL] [Abstract][Full Text] [Related]
16. Synthetic nano-low density lipoprotein as targeted drug delivery vehicle for glioblastoma multiforme.
Nikanjam M; Blakely EA; Bjornstad KA; Shu X; Budinger TF; Forte TM
Int J Pharm; 2007 Jan; 328(1):86-94. PubMed ID: 16959446
[TBL] [Abstract][Full Text] [Related]
17. Loading anticancer drugs into HDL as well as LDL has little affect on properties of complexes and enhances cytotoxicity to human carcinoma cells.
Kader A; Pater A
J Control Release; 2002 Apr; 80(1-3):29-44. PubMed ID: 11943385
[TBL] [Abstract][Full Text] [Related]
18. Theranostic applications of nanoparticles in neurodegenerative disorders.
Ramanathan S; Archunan G; Sivakumar M; Tamil Selvan S; Fred AL; Kumar S; Gulyás B; Padmanabhan P
Int J Nanomedicine; 2018; 13():5561-5576. PubMed ID: 30271147
[TBL] [Abstract][Full Text] [Related]
19. Correlation of low and high density lipoprotein binding in vivo with rates of lipoprotein degradation in the rat. A comparison of lipoproteins of rat and human origin.
Koelz HR; Sherrill BC; Turley SD; Dietschy JM
J Biol Chem; 1982 Jul; 257(14):8061-72. PubMed ID: 6282871
[TBL] [Abstract][Full Text] [Related]
20. Transporting mitochondrion-targeting photosensitizers into cancer cells by low-density lipoproteins for fluorescence-feedback photodynamic therapy.
Wang C; Zhao X; Jiang H; Wang J; Zhong W; Xue K; Zhu C
Nanoscale; 2021 Jan; 13(2):1195-1205. PubMed ID: 33404030
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
